nasea and vomitting. ???? ? ???????
Conditions
Interventions
Intervention 1: Control Group:
Intramuscular injection of Ketamin 4 mg/kg. Intervention 2: Intervention Group:
Intramuscular injection of Ketamine 4 mg/kg
+
Ondansetron 0.1 mg/kg (max 2mg) in the sam
Treatment - Drugs
Control Group:
Intramuscular injection of Ketamin 4 mg/kg
Intervention Group:
Intramuscular injection of Ketamine 4 mg/kg
+
Ondansetron 0.1 mg/kg (max 2mg) in the same syringe
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 10 Years
Inclusion criteria
Inclusion criteria: Exclusion criteria are: allergy to ketamine or ondansetron, seizure, air way disease, head trauma, uncontrolled high blood pressure and vomiting associated with other diseases.children (6 months to 10 years) who will referre to emergency department of Imam or Shariati hospitals will be included.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vomitting. Timepoint: before procedure/during procedure/after discharge. Method of measurement: with quastion form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse Rate. Timepoint: Continuously during procedure time. Method of measurement: Pulse Oximetry.;Saturation of peripheral O2 (SpO2). Timepoint: Continuously during procedure time. Method of measurement: Pulse Oximetry.;Other Side effects like: Seizure, Shivering,. Timepoint: In Recovery Period. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Akbari
Emam Khomeyni Hospital
Outcome results
None listed